Clinical Trials in Arizona

Showing 3001-3020 of 14,395 trials

A Study To Evaluate the Relative Bioavailability, Food Effect, and Dose Proportionality of a Granule Formulation of Vanzacaftor/Tezacaftor/Deutivacaftor(VNZ/TEZ/D-IVA)

NCT06299709

The purpose of this study is to evaluate the relative bioavailability, food effect, and dose proportionality of a granule formulation of VNZ/TEZ/D-IVA.

Cystic Fibrosis

Vertex Pharmaceuticals Incorporated34 participantsStarted Mar 2024

Tempe, Arizona, United States

COMPLETEDPhase 342 miles

A Study to Evaluate the Long-Term Safety of BLI5100 in Patients With Gastroesophageal Reflux Disease

NCT05890001

The objective of this study is to evaluate the safety of up to 12 months (52 weeks) of once daily oral administration of BLI5100 in patients with non-erosive reflux disease (NERD) or healed erosive esophagitis (EE).

Non-erosive Reflux DiseaseErosive Esophagitis

Braintree Laboratories400 participantsStarted Apr 2023

Huntsville, Alabama, United States • Phoenix, Arizona, United States • Tucson, Arizona, United States +57 more locations

A Study To Evaluate the Relative Bioavailability, Food Effect, and Dose Proportionality of a Granule Formulation of Vanzacaftor/Tezacaftor/Deutivacaftor(VNZ/TEZ/D-IVA)

A Study to Evaluate the Long-Term Safety of BLI5100 in Patients With Gastroesophageal Reflux Disease

Find Trials by Condition in Arizona

Financial Difficulty in Patients With Blood Cancer

Anti-viral Therapy in Alzheimer's Disease

ENCALM: A Study of ENX-102 as a Monotherapy Treatment in Patients With Generalized Anxiety Disorder

A Registry for Participants With Chronic Hypoparathyroidism

Treatment of Refractory Nausea and Vomiting in Patients With Breast Cancer

Beta-Agonist Versus OnabotulinumtoxinA Trial for Urgency Urinary Incontinence

Study of OCA in Combination With BZF Evaluating Efficacy, Safety and Tolerability in Participants With PBC

Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission

A Study to Evaluate Safety and Efficacy of Empasiprubart in Adults With Dermatomyositis

Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.

A Study of Cabozantinib Compared With Placebo in Subjects With Radioiodine-refractory Differentiated Thyroid Cancer Who Have Progressed After Prior Vascular Endothelial Growth Factor Receptor (VEGFR) -Targeted Therapy

A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome

Edwards CLASP TR EFS

Master Rollover Protocol for Continued Safety Assessment of Study Drug

An Early Feasibility Study Evaluation of an Implant Free Interatrial Shunt to Improve Heart Failure

Diagnosis and Treatment of CAD in Severe PAD After Lower Extremity Revascularization

GM1 and GM2 Gangliosidosis PROspective Neurological Disease TrajectOry Study (PRONTO)

An Observational Registry of Abatacept in Patients With Juvenile Idiopathic Arthritis